How genetic variations in apoptosis pathway interact with environmental factors to contribute to esophageal adenocarcinoma (EA) risk has not been comprehensively investigated. We conducted a case-only analysis in 335 Caucasian EA patients that were genotyped for 242 single nucleotide polymorphisms (SNPs) in 43 apoptotic genes. Gene-environment interactions were assessed using a two-step approach. First, random forest algorithm was used to screen for the potential interacting markers. Next, we used case-only logistic regression model to estimate the effects of gene-environment interactions on EA risk. Four SNPs (PERP rs648802; PIK3CA rs4855094, rs7644468 and TNFRSF1A rs4149579) had significant interaction with gastroesophageal reflux disease (GERD). The presence of variant alleles in TP53BP1 rs560191, CASP7 rs7907519 or BCL2 rs12454712 enhanced the risk of smoking by 2.08-2.58 times [interaction odds ratio (ORi) 5 2.08-2.58, adjusted P-value (P adj ) 5 0.02-0.04]. Compared with patients carrying £1 risk genotype, the risk of GERD on EA was increased in persons with two (ORi 5 1.89, P adj 5 0.016) or ‡3 (ORi 5 4.30, P adj < 0.0001) risk genotypes. Compared with cases with £1 risk genotype, smoking-associated EA risk increased by 3.15 times when ‡2 risk genotypes were present (ORi 5 3.15, P adj < 0.0001). In conclusion, interactions among apoptotic SNPs and GERD or smoking play an important role in EA development.
IntroductionCumulative evidence has indicated that symptomatic gastroesophageal reflux disease (GERD), obesity, smoking and male gender are four major risk factors for developing esophageal adenocarcinoma (EA) (1,2). Although GERD is the strongest individual risk factor and subjects who have the most frequent reflux symptom carry .4-fold EA risk, most of them follow an indolent course for the entire life (3). On the other hand, nearly 50% of EA patients do not experience GERD-associated symptoms (2,4,5). Therefore, challenges arise when considering the benefit and cost of endoscopic surveillance for EA among subjects with these risk factors, especially GERD (6). One of the explanations for this phenomenon stems from the complex interactions between lifestyle/environmental exposure and genetic factors. Since most EA cases are sporadic, genetic influences are more probably to be polymorphisms in multiple genes instead of single gene mutation. Evidence from pathway-based studies suggests that genetic variance may modulate the susceptibility of developing EA (7-9). Incorporating one's genetic background in the clinical setting could be a better strategy for risk assessment and cancer surveillance, and possibly provide a better understanding about how complex factors contribute to EA risk jointly. However, fewer studies have assessed interactions using a more comprehensive approach.Apoptosis, or programmed cell death, is essential for normal tissues to regulate cell number and to eliminate unwanted or aging cells as an organism develops. Mutations and single nucleotide polymorphisms (SNPs) in apoptotic pathway...